10/05/2026
New York just approved higher 2027 health insurance rates, and the public conversation about why fails to include one key player: pharmacy benefit managers (PBMs), the middlemen that decide what a health plan pays for a drug and what a pharmacy is paid for it, and that often keep a share of the manufacturer rebates tied to the drug costs insurers cite when raising premiums. At the same time, these PBMs routinely pay pharmacies less than it costs to acquire and dispense patients' medicines, and when pharmacies can no longer absorb those losses and close their doors, patients are left without convenient access to care.
A new column from the Community Pharmacy Association of New York State makes the case for the Patient Access to Pharmacy Act, which stops those below-cost payments from PBMs so New Yorkers can keep the pharmacies and pharmacists they trust. Governor Kathy Hochul, when PAPA reaches your desk, please sign it into law.
The Department of Financial Services (DFS) has just announced 2027 health insurance rates across New York and has approved an average increase of 6% for the individual market and 8% for the small group market. Thereβs already a long overdue conversation underway about why those numbers look the wa...